Tusp

Emotional tension, anxiety, concentration difficulties, vegetative neurosis, problems with falling asleep resulting from the neurotic disorders.

Child: 1-3yrs: 2.5-5ml. 3-6yrs: 5-10ml. Both tid-qid.

Tusp, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyine is contraindicated in early pregnancy.

Tusp is contraindicated for patients who have shown a previous hypersensitivity to it.

Headache, sports injuries, backpain, musculoskeletal disorders, chronic diarrhoea.

THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND BARBITURATES. Therefore when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced.

Since drowsiness may occur with use of this drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery while taking Atarax. Patients should be advised against the simultaneous use of other CNS depressant drugs, and cautioned that the effect of alcohol may be increased.

Drowsiness, weakness, nausea, dizziness, skin rash, flushing of skin, confusion, excitement, depression, dryness of mouth. Cholestatic jaundice may occur.

Potentially Fatal: Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

Tusp is an antihistamine of the piperazine derivative family.